Humanin is a peptide investigated in cell-survival research, including models related to Alzheimer's disease. Cell mechanisms should not be presented as demonstrated disease prevention or treatment in people.
What the research shows
A 2001 study examined neuronal protection in amyloid- and mutation-related cell models. Another study that year used the [Gly14]-Humanin analogue in a mouse memory model. Both the materials and models differ from a human trial of a Humanin product. [1] [2]
Distinguishing substances and products
Humanin and analogues such as [Gly14]-Humanin need explicit identification. MOTS-c is another distinct substance. An analogue's findings do not certify the properties of a product labelled only Humanin.
Reading a specific brand’s label
Start with the exact substance and product name, then match the label to the manufacturer’s documents. This article does not establish Thai registration or current availability for an unspecified product.
Frequently asked questions
Do the cited studies establish Humanin as an Alzheimer's treatment?
No. They use cells and animals, not patient-treatment outcomes.
Are Humanin and [Gly14]-Humanin evidence interchangeable?
Not automatically. The material actually studied must be identified.
What information helps identify a specific product?
The brand, product name, full label and matching manufacturer documents. Evidence about the substance alone does not establish a product’s identity, registration or quality.
Related information
For general questions about names or label details, contact LINE: @musclestationth
Sources and review date
Sources checked: 11 September 2026. This page explains selected primary sources; it is not a systematic review of every study.